Entry Instance

HTTP 200 OK
Allow: GET, PUT, PATCH, DELETE, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "id": 1019408,
    "url": "https://info.mzalendo.com/api/v0.1/hansard/entries/1019408/?format=api",
    "text_counter": 122,
    "type": "speech",
    "speaker_name": "Mvita, ODM",
    "speaker_title": "Hon. Abdullswamad Nassir",
    "speaker": {
        "id": 2433,
        "legal_name": "Abdulswamad Sheriff Nassir",
        "slug": "abdulswamad-sheriff-nassir"
    },
    "content": " Hon. Speaker, pursuant to Standing Order No. 44(2) (c), I wish to request for a Statement from the Chairperson of the Departmental Committee on Health on the status of the Oxford University’s COVID-19 Vaccine trials in the country. Hon. Speaker, the Kenya Medical Research Institute (KEMRI) is currently engaged in multilateral partnership with the Welcome Trust and the University of Oxford under the KEMRI- Welcome Trust Collaborative Research Programme aimed at expanding the country’s capacity to conduct multidisciplinary medical research. Further, Oxford University has engaged AstraZeneca Plc, which is a British-Swedish multinational biopharmaceutical company based in Cambridge, England, to develop a COVID-19 vaccine on its behalf by conducting differentiated human trials in Kenya. However, we take note, with great concern, that similar COVID-19 vaccine trials were halted in the United Kingdom (UK) several days ago. As such, I fail to understand the rationale behind their continued experimentation in this country. It is on account of this expectation that I seek a Statement from the Chairperson of the Departmental Committee on Health on the following: (i) Has any COVID-19 vaccine trials been undertaken in Kenya since the outbreak of pandemic and are there any clinical trials currently in progress in Kenya? (ii) What prompted the suspension of AstraZeneca COVID-19 vaccine trials in the UK and was a similar suspension done in Kenya? (iii) Were key stakeholders in the country consulted before Oxford University was given the greenlight to conduct its COVID-19 vaccine trials in Kenya? (iv) How many similar COVID-19 clinical trials have been carried out in the country so far and what is their respective status? Thank you."
}